IFG* | IGT† | Total pre-diabetes (IFG or IGT) | Dysglycemia | |
N | 6525 | 4827 | 4827 | 4827 |
All adults | 23.2 (21.3 to 25.1) | 18.9 (17.0 to 20.8) | 30.5 (28.2 to 32.7) | 53.4 (50.8 to 56.1) |
Age (years) | ||||
18–29 | 13.3 (10.4 to 16.3) | 14.0 (10.8 to 17.3) | 21.7 (17.9 to 25.5) | 25.4 (21.5 to 29.2) |
30–39 | 22.9 (18.9 to 27.0) | 20.8 (16.4 to 25.1) | 32.1 (27.2 to 37.0) | 47.7 (43.1 to 52.3) |
40–49 | 24.7 (21.2 to 28.2) | 22.6 (18.4 to 26.8) | 32.9 (28.6 to 37.2) | 60.3 (55.8 to 64.9) |
50–59 | 29.3 (25.7 to 32.8) | 19.4 (15.9 to 23.0) | 36.5 (32.0 to 41.0) | 71.9 (67.2 to 76.6) |
60–69 | 27.7 (23.8 to 31.5) | 17.5 (14.0 to 21.0) | 31.4 (26.7 to 36.1) | 74.2 (69.7 to 78.7) |
70–79 | 30.4 (26.5 to 34.3) | 19.7 (15.0 to 24.5) | 35.0 (29.0 to 41.0) | 72.9 (66.7 to 79.0) |
80+ | 38.7 (27.6 to 49.8) | 26.9 (13.8 to 39.9) | 33.8 (20.8 to 46.9) | 72.9 (59.2 to 86.6) |
Sex | ||||
Men | 25.2 (22.8 to 27.7) | 14.4 (12.2 to 16.7) | 30.3 (27.5 to 33.0) | 50.4 (47.4 to 53.3) |
Women | 21.4 (19.3 to 23.5) | 22.9 (20.2 to 25.5) | 30.7 (27.7 to 33.7) | 56.2 (52.8 to 59.6) |
BMI (kg/m2) | ||||
Underweight (<18.5) | 16.4 (13.1 to 19.7) | 11.2 (7.7 to 14.6) | 21.4 (16.6 to 26.2) | 28.2 (22.6 to 33.8) |
Normal (18.5–24.9) | 23.1 (20.5 to 25.7) | 15.8 (13.8 to 17.8) | 29.4 (26.6 to 32.2) | 50.0 (46.6 to 53.4) |
Overweight (25.0–29.9) | 23.8 (21.1 to 26.6) | 23.0 (19.8 to 26.1) | 32.2 (28.8 to 35.6) | 62.1 (58.7 to 65.5) |
Obese (≥30) | 30.7 (25.8 to 35.7) | 30.5 (24.4 to 36.7) | 42.4 (35.7 to 49.2) | 74.0 (69.0 to 79.1) |
Asian BMI categories (kg/m2) | ||||
Underweight (<18.5) | 16.4 (13.1 to 19.7) | 11.2 (7.7 to 14.6) | 21.4 (16.6 to 26.2) | 28.2 (22.6 to 33.8) |
Normal (18.5–22.9) | 21.4 (18.6 to 24.1) | 14.1 (11.6 to 16.6) | 27.9 (24.6 to 31.1) | 46.1 (42.2 to 50.0) |
Overweight (23.0–24.9) | 26.5 (22.8 to 30.3) | 19.2 (15.5 to 22.8) | 32.4 (27.7 to 37.1) | 57.7 (52.3 to 63.1) |
Obese (≥25) | 25.5 (23.1 to 28.0) | 24.8 (21.9 to 27.6) | 34.6 (31.3 to 37.9) | 65.0 (62.1 to 67.9) |
Estimates are given as % (95% CI). All estimates are weighted as described in text to match the Sri Lankan adult population in 2019 with respect to age, sex, ethnicity, region and area socioeconomic development.
*IFG 100–126 mg/dL.
†IGT 2-hour plasma glucose 140–199 mg/dL.
BMI, body mass index; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; SLHAS, Sri Lanka Health and Ageing Study.